{"name":"Geneos Therapeutics","slug":"geneos-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOM2xwWFMzalhuNlJncHdMejZIbzQ4Yzl3VVFrX1otTkVUcGkwOWJOOHBGMTZ0aG5YTUR3QVo5eER6dGRxOGpWR1BZNEJna2lEQnVJREU5VFVEcHotVzBZSko4WVFIbWJLZER0TzBaekwxRzR3UEhka0N5M3RhT0ZaZFh6WGtwVm9mTnI1WU9KcnljRHItSk1rdHVlWQ?oc=5","date":"2026-04-02","type":"pipeline","source":"TradingView","summary":"NET ASSET VALUE – 31 March 2026 - TradingView","headline":"NET ASSET VALUE – 31 March 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPUnpOeXhoczBENjI3NUw0bFhQU2l2Um1lMXVPNUZkMmNSelFoUHUyQWR1NVE3N0tobU1xWHJxQUNWWU13MVNiS1MxVmwtSDlVWVYyTmwxLXc2NlJvLW85UGtsQndPQi1sQ0lsVDJPdXlmYVZxd2RCN29mcjY3bW1OR0VmQllTeFZ1QWFRQzFJUlhHWEhIaWhCSw?oc=5","date":"2026-03-10","type":"trial","source":"openPR.com","summary":"Advanced Hepatocellular Carcinoma Clinical Trial Pipeline - openPR.com","headline":"Advanced Hepatocellular Carcinoma Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxOa01QdWp6ZndUT2xyT01KSUNBTHcxNGhkampLR2stYnkzUjE3NFBxcFRtOXQ0NE93QXhxMWxjVHM4c0tkZWFDYi1EcDBSSk43SVBzdE1GMVdiZy0xVFd5UUFPeW1xaFc1RWNJWERCYUk4N2k3Tjk4WTJ3T3lWR1I5WlFSeWpnaDdDWXRpVTVmMWE2dWhyTnNndW9QdnM3Q3ZvWHRnM1NWcDJMRmc0WXFCOFg1NWFXMUtJR1dwMEV1RkVON0lFQWM3c0JfQVpyd1RzWlZuYi1vVFNEQXc1XzdnaGN3QU5OUGo3NkVDWENrdjl6YjZKMTRrOVdqQ2RlUVJwYlMxdVBzNEVQbEhYX0FYcjZ2LV9jcndydk9RNmNXUHRpTUVKU1J5TU1uRF9oZmt2c0hhYW5hT2JxNkJPZ1JCcQ?oc=5","date":"2025-12-11","type":"pipeline","source":"Business Wire","summary":"Neoantigen Cancer Vaccines Market to Nearly Triple by 2032 Reaching $1.19 Billion: Analysis of Key Opportunities and 26 Industry Players - ResearchAndMarkets.com - Business Wire","headline":"Neoantigen Cancer Vaccines Market to Nearly Triple by 2032 Reaching $1.19 Billion: Analysis of Key Opportunities and 26 ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPUHFqWHVqaVhSRWNPOVo5QXBrRVZBeWhubG5ZUUFUNTMyNWFULW9zTTVZRDZTWTRSOGc2dl8zMmFFU2czM1ZCd2ExRGw2dkNobEtlNmFiamNSUXhfMzhnWWhuSGl3ZXdRMlQ4blZ2d1BxNWJjR0p3ZDBSVTRzTENQZQ?oc=5","date":"2025-04-09","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Cancer Vaccines Improve Their Aim - Genetic Engineering and Biotechnology News","headline":"Cancer Vaccines Improve Their Aim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNRDM4S1BQd1FSWGJaVWVlS2stelQ5S2NnNWhFNURtUUZ4TDhHWlN3cVVsclhpWXBMYTVpQ3Z6dzBUU0tJajlDV3ZYbXRaS2xHLVJxVW5GRmpkVVlqUlM1T3NQWTZ1MXA3T1JrNUU2YzFBUHhIVW1ibWZkTXRMcWV2bGxndEhCdldMTjhiZU1wVmhGcmN0cnFWYkxRc3hubDlDTUdSMkRaTlFZdlBQS3ZUSjM3WC1RZUJBamxfSVF3?oc=5","date":"2024-04-09","type":"pipeline","source":"PharmaTimes","summary":"US researchers reveal positive results of personalised vaccine for liver cancer - PharmaTimes","headline":"US researchers reveal positive results of personalised vaccine for liver cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9fSmsxcFlnUmp2VDFOck1DZV9pcHlVTUFNbk41TnNrWkx3SkdyalVuUGRNWG9hYnI1cjJUWnNNRVJfU2pXdFRTZDFBMHlVdTdTU0xJQ3N1ekpsRjE3ejBF?oc=5","date":"2024-04-07","type":"trial","source":"Nature","summary":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial - Nature","headline":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPa21YblpkbjJiQ0w4cnRHUS1mNTU5MW5MeVBna1ljN1pGUm5QenRBZUhTUTM3YmcwQ1laT0haYUdJVlZYbUp6eTNWQnV4Zzg1amZMajktZGdIWTVtNm45QUxEbjFyTkN1a1BPcERxQnhqampCQjFINWc5ZERHSnJvS0hKcUdhbGh4LTRORWRmbVdCRDA?oc=5","date":"2022-10-12","type":"pipeline","source":"citybiz","summary":"Geneos Announces Elects Dr. Laurent Humeau to Board - citybiz","headline":"Geneos Announces Elects Dr. Laurent Humeau to Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTFBQOHU5YXFnS2VNcC14eFNabFM3UkxZZFp0UFd0ODFqaUpKSmE4Zm92V2llbmRDM013Zi12OXNHQ09FNkxlM3hOUA?oc=5","date":"2021-02-18","type":"pipeline","source":"eToro","summary":"INO Stock Price | Analyst Target 3.00 & Hold Consensus - eToro","headline":"INO Stock Price | Analyst Target 3.00 & Hold Consensus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQaS1yMjJ3TW1pbFJ4OUgtZ2JiMHB3TGlOQmUzS0xWOVVEdWFDZ25hbVlOanlvSzlLeWNEWEE0UlFXRU51NmNQXzNZaGRFdG1hd2JTYXdnUlRkSGlaWEhDYURYSVA1cXozeDRUelJkSDZOd3dXY0pBUm0yS1Q5bXRfR1I4ZnNKZnRuSElGQk9mak9pbTkwdFVpU2o0Ym8?oc=5","date":"2019-07-23","type":"pipeline","source":"BioProcess International","summary":"VGXI to supply plasmid for Geneos’ cancer DNA vaccines - BioProcess International","headline":"VGXI to supply plasmid for Geneos’ cancer DNA vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPMkNMejdZa2JHb1JPb0hRWE00amY1M2lRMGg1SENRVk1iUUJfTGo3WVUxTFNkdnVsUmprTEU4c041UlhmMVZzVmxNaVJYSGhWOXlEQy1iejZfbnRrelAtSXk4UEhMbUlKeGJ2amtlZ0VEOU1KMHpuaVhaQnF0MWc3TlBFMDlBZGpPTEI1N2ZOb0xwQ2ll?oc=5","date":"2019-02-22","type":"pipeline","source":"Fierce Biotech","summary":"I-O startup Geneos raises $10.5M for neoantigen drugs - Fierce Biotech","headline":"I-O startup Geneos raises $10.5M for neoantigen drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}